Brief: Hansa Biopharma Announces Encouraging High-Level Results For First-In-Human Trial Of Hnsa-5487
09/10/2023 19:17
Oct 9 (Reuters) - Hansa Biopharma AB HNSA.ST :
* HANSA BIOPHARMA ANNOUNCES ENCOURAGING HIGH-LEVEL RESULTS
FOR
FIRST-IN-HUMAN TRIAL OF HNSA-5487
Source text for Eikon: ID:nPn5DS5TPa
Further company coverage: HNSA.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS